drugset / Trial / NCT06400004
Lumason® Infusion vs. Bolus Administrations
RandomizedCrossoverSingle-blindDiagnostic
Summary
A phase III study designed as a randomized, within-patient comparison of continuous infusion of diluted Lumason® versus the bolus administration of undiluted Lumason® for degree of LVO and assessment of LV EBD (co-primary endpoints).
Timeline
- Start
- 2024-07-10
- Primary completion
- 2026-05-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lumason | Diagnostic / imaging agent | 2 ml | — |
| Comparator | Lumason | Diagnostic / imaging agent | 4 ml | — |